文献速递胰腺与胆道疾病消化道出血

中重度胆管炎患者常规与短疗程抗生素比较:非劣效随机试验

Conventional vs Short Duration of Antibiotics in Patients With Moderate or Severe Cholangitis: Noninferiority Randomized Trial.
PubMed 文献 · Am J Gastroenterol · 2023-09-21

单中心随机非劣效试验纳入120例中重度胆管炎患者,比较常规疗程(8天)与短疗程(4天)抗生素。第30天临床治愈率常规组79.66% vs 短疗程组77.97%(P=0.822),短疗程组抗生素总天数更少(8.58±1.92 vs 4.75±2.32天,P<0.001),住院时长与死亡率两组相似。

要点

  • 短疗程抗生素在中重度胆管炎患者中临床治愈率非劣效于常规疗程。
  • 短疗程组抗生素总天数显著少于常规组(8.58±1.92 vs 4.75±2.32天,P<0.001)。
  • 恶性肿瘤病因和就诊时低血压与较低的临床治愈率相关。

核心结论

  • 在中重度胆管炎患者中,短疗程抗生素在临床治愈、胆管炎复发和总体死亡率方面非劣效于常规疗程。

研究设计与样本

  • 单中心、随机、非劣效试验,连续筛查并纳入120例中重度胆管炎患者,随机分为常规疗程组(8天)和短疗程组(4天)。

主要发现

  • 常规疗程组临床治愈率为79.66%(95%CI 67.58%-88.12%),短疗程组为77.97%(95%CI 65.74%-86.78%),P=0.822。
  • 短疗程组干预后抗生素总天数低于常规疗程组(8.58±1.92天 vs 4.75±2.32天,P<0.001)。
  • 两组住院时长和死亡率相似。
  • 多因素分析显示,恶性肿瘤病因和就诊时低血压与较低的临床治愈率相关。

关键数值与推荐

  • 主要结局临床治愈定义为第30天无胆管炎复发且第15天胆红素下降>50%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Successful biliary drainage and antibiotics are the mainstays of therapy in management of patients with acute cholangitis. However, the duration of antibiotic therapy after successful biliary drainage has not been prospectively evaluated. We conducted a single-center, randomized, noninferiority trial to compare short duration of antibiotic therapy with conventional duration of antibiotic therapy in patients with moderate or severe cholangitis. METHODS: Consecutive patients were screened for the inclusion criteria and randomized into either conventional duration (CD) group (8 days) or short duration (SD) group (4 days) of antibiotic therapy. The primary outcome was clinical cure (absence of recurrence of cholangitis at day 30 and >50% reduction of bilirubin at day 15). Secondary outcomes were total days of antibiotic therapy and hospitalization within 30 days, antibiotic-related adverse events, and all-cause mortality at day 30. RESULTS: The study included 120 patients (the mean age was 55.85 ± 13.52 years, and 50% were male patients). Of them, 51.7% patients had malignant etiology and 76.7% patients had moderate cholangitis. Clinical cure was seen in 79.66% (95% confidence interval, 67.58%-88.12%) patients in the CD group and 77.97% (95% confidence interval, 65.74%-86.78%) patients in the SD group ( P = 0.822). On multivariate analysis, malignant etiology and hypotension at presentation were associated with lower clinical cure. Total duration of antibiotics required postintervention was lower in the SD group (8.58 ± 1.92 and 4.75 ± 2.32 days; P < 0.001). Duration of hospitalization and mortality were similar in both the groups. DISCUSSION: Short duration of antibiotics is noninferior to conventional duration in patients with moderate-to-severe cholangitis in terms of clinical cure, recurrence of cholangitis, and overall mortality.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Srinu D, Shah J, Jena A, et al. Conventional vs Short Duration of Antibiotics in Patients With Moderate or Severe Cholangitis: Noninferiority Randomized Trial. Am J Gastroenterol. 2023. PMID: 37732816. doi:10.14309/ajg.0000000000002499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。